user-group INVESTOR ACCESS
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. MRM Health Reports Preclinical...

Venture Capital

MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis

6 June 2022

Download

Press Release
Download

Related News

  • Venture Capital
  • Recent investments & divestments

Mérieux Innovation 2 invests in Ona Therapeutics, a Spanish biopharmaceutical company

arrow-up-right
  • Buyout
  • Buyout

Mérieux Equity Partners Announces the Exit of a Majority of its Stake in Swixx Biopharma

arrow-up-right
Icone-Merieux-partners
  • Other news

Mérieux Equity Partners announces the appointment of Quentin de Labarre to Partner, along with several other promotions across the firm

arrow-up-right